| Date | Time | Source | Headline | Symbol | Company |
| 10/30/2006 | 9:07AM | PR Newswire (US) | Novogen Limited to Present at the Rodman & Renshaw 8th Annual Healthcare Conference | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 10/30/2006 | 9:06AM | PR Newswire (US) | Statement from Novogen Limited | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 10/23/2006 | 9:00AM | PR Newswire (US) | Natrol Acquires U.S. Rights to Promensil(R) and Trinovin(R) Brands from Novogen | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 09/19/2006 | 10:34AM | PR Newswire (US) | Marshall Edwards, Inc. to Present at the UBS Global Life Sciences Conference | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 09/18/2006 | 9:54AM | PR Newswire (US) | Marshall Edwards, Inc. to Present at the UBS Global Life Sciences Conference | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 09/18/2006 | 9:51AM | PR Newswire (US) | Early Study Provides Evidence That Investigational Drug Phenoxodiol Targets Prostate Cancer Protein | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 09/15/2006 | 9:50AM | PR Newswire (US) | Early Study Provides Evidence That Investigational Drug Phenoxodiol Targets Prostate Cancer Protein | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 08/25/2006 | 10:36AM | PR Newswire (US) | Novogen Cash Reserves $25.4M, Phenoxodiol Receives US FDA Clearance for Phase III Human Trial | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 08/09/2006 | 11:42AM | PR Newswire (US) | Investigational Drug Targeting Inflammatory Bowel Disease Enters Second Human Clinical Trial | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 07/12/2006 | 7:15PM | PR Newswire (US) | Marshall Edwards, Inc. Raises a Total of Approximately $18 Million in Private Equity Financings; Enters Into $15 Million Equity | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 07/12/2006 | 10:42AM | PR Newswire (US) | Marshall Edwards, Inc. Raises Approximately $14 Million in Private Equity Financing | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 06/20/2006 | 9:00AM | PR Newswire (US) | Austrian Court Upholds Novogen Patent for Red Clover Isoflavones | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 06/07/2006 | 11:49AM | PR Newswire (US) | Novogen Renegotiates Phenoxodiol License Payment | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 05/16/2006 | 9:57AM | PR Newswire (US) | Marshall Edwards Achieves Special Protocol Assessment and Agreement With FDA on Phase III (Ovature Study) of Phenoxodiol as a C | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 05/15/2006 | 9:01AM | PR Newswire (US) | Marshall Edwards, Inc. Licenses Two Anti-Cancer Compounds From Novogen Limited | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 03/31/2006 | 9:30AM | PR Newswire (US) | Marshall Edwards, Inc. to Present at the CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 03/29/2006 | 9:38AM | PR Newswire (US) | Appointment of New Governor Creates Board Vacancy at Marshall Edwards, Inc. | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 03/29/2006 | 9:28AM | PR Newswire (US) | Yale Researchers Find Phenoxodiol Restores Sensitivity to Chemotherapy in Some Women With Ovarian, Fallopian Tube or Primary Pe | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 03/02/2006 | 9:15AM | PR Newswire (US) | Data From Novogen Inflammatory Bowel Disease Drug Phase I Clinical Trial Shows Promise | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 01/18/2006 | 8:34AM | PR Newswire (US) | Novogen Appeals Injunction Decision in the Netherlands | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 01/17/2006 | 4:30PM | PR Newswire (US) | New CEO and President for Glycotex Inc. | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 01/11/2006 | 12:18AM | PR Newswire (US) | Glycotex, Inc. Postpones Proposed Initial Public Offering of Its Common Stock Units | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 11/28/2005 | 3:19PM | PR Newswire (US) | New Clinical Study of Phenoxodiol as Chemo-sensitizer for Docetaxel in Ovarian Cancer Commences at Yale University School of Med | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 11/17/2005 | 12:30PM | PR Newswire (US) | Phenoxodiol Delays Tumor Progression in Late-Stage Hormone Refractory Prostate Cancer | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 11/17/2005 | 12:30PM | PR Newswire (US) | Researchers Report That Phenoxodiol Produces Anti-Cancer Responses in Women With Cervical Cancer | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 11/04/2005 | 12:12PM | PR Newswire (US) | Novogen Clarifies Confusion, Issues Letter to Shareholders | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 10/24/2005 | 12:26PM | PR Newswire (US) | Researchers Report That Phenoxodiol is Producing Significant Anti-Cancer Responses in Women With Gynecological Cancers | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 09/13/2005 | 10:11AM | PR Newswire (US) | Novogen Investigational Drug Improves Cardiovascular Risk in Human Trials | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 09/13/2005 | 9:00AM | PR Newswire (US) | Novogen Limited Announces Its Intention to List Glycotex Inc on the Nasdaq National Market | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 09/02/2005 | 9:37AM | PR Newswire (US) | Novogen Announces Development and Expansion of U.S. Subsidiary Companies | NASDAQ:KZIA | Kazia Therapeutics Ltd |